Aegis Capital Starts Matinas BioPharma Holdings Inc. (MTNB) at Buy
Tweet
Share
E-mailGet Alerts MTNB Hot Sheet
Price: $0.29 -9.38%
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Join SI Premium – FREE
Aegis Capital analyst Nathan Weinstein initiates coverage on Matinas BioPharma Holdings Inc. (NYSE: MTNB) with a Buy rating and a price target of $3.50.
For an analyst ratings summary and ratings history on Matinas BioPharma Holdings Inc. click here. For more ratings news on Matinas BioPharma Holdings Inc. click here.
Shares of Matinas BioPharma Holdings Inc. closed at $1.64 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Starts Duos Technologies Group (DUOT) at Overweight, 'Under The Radar AI Data Center Play'
- GH Power and TKMS Continue to Explore Clean Energy Collaboration in Support of Canada’s Future Patrol Submarine Project
- Raymond James Starts Faeth Therapeutics (FTH) at Outperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
